# Fractures in Parkinson’s Disease: Pathophysiology, Prevention, and Orthopedic Outcomes

**Authors:** Ali Osman, Tala Maya, Rayyan Bhutta, Natasha Doshi, Maryam Khan, Sara Shah, Paslene Periceles, Janae Rasmussen

PMC · DOI: 10.7759/cureus.92946 · Cureus · 2025-09-22

## TL;DR

Fractures are a significant issue in Parkinson’s disease due to mobility issues and bone loss, and new prevention strategies are needed to improve patient outcomes.

## Contribution

The paper reframes skeletal fragility in PD as a primary consequence of the disease rather than a secondary complication.

## Key findings

- Hip fractures in PD patients lead to longer hospital stays and reduced independence.
- Current fracture prevention strategies in PD are underutilized despite available evidence-based interventions.
- New approaches like telerehabilitation and bone-protective therapies show promise but are not widely adopted.

## Abstract

Fractures are an important comorbidity in Parkinson’s disease (PD), which can result in disability, mortality, and high healthcare costs. Impaired mobility, postural instability, bradykinesia, muscle rigidity, and decreased bone mineral density (BMD) contribute to the increased risk of falls, which often result in hip and upper extremity fractures. Hip fractures in patients with PD are associated with an increased hospital length of stay and a decline in functional independence. Multimodal fall prevention in PD is well established, but prevention of fractures is often underutilized, despite evidence-based interventions. Information on fall-related fracture outcomes after exercise interventions is an area warranting further investigation. Several new strategies, such as home-based telerehabilitation (TR) and pharmacologic agents, show promise but are not yet widely implemented in care. While screening tools and risk stratification methods are available, most patients with PD are not screened for skeletal fragility or entered into a structured prevention program. This review proposes a reframing of skeletal fragility in PD from a problem of secondary complications, amenable to treatment only after the fact, to a primary and expected consequence of neuromotor dysfunction in this disease. When fracture risk is considered a core and predictable outcome of PD progression, the integration of new models of care may be accelerated that combine movement therapy, bone-protective interventions, and proactive surgical planning to improve long-term outcomes.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Diseases:** neuromotor dysfunction (MESH:D006331), skeletal fragility (MESH:D005600), PD (MESH:D010300), Hip fractures (MESH:D006620), Impaired mobility (MESH:D014086), bradykinesia (MESH:D018476), Fractures (MESH:D050723), muscle rigidity (MESH:D009127), postural instability (MESH:D054972), fall (MESH:C537863)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12543220/full.md

## References

97 references — full list in the complete paper: https://tomesphere.com/paper/PMC12543220/full.md

---
Source: https://tomesphere.com/paper/PMC12543220